High Tower Advisors, LLC Capricor Therapeutics, Inc. Call Options Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.56 - $15.21 $39,160 - $167,310	11,000 Added 122.22%	20,000 $304,000
Q2 2024 Aug 13, 2024	SELL	$4.63 - $7.09 $69,450 - $106,350	-15,000 Reduced 62.5%	9,000 $42,000
Q1 2024 May 06, 2024	BUY	$3.61 - $6.88 $86,640 - $165,120	24,000 New	24,000 $162,000
Q2 2022 Aug 10, 2022	BUY	$2.89 - $4.51 $19,912 - $31,073	6,890 Added 6263.64%	7,000 $11,000
Q1 2022 May 12, 2022	SELL	$2.83 - $5.68 $31,667 - $63,559	-11,190 Reduced 99.03%	110 $5,000
Q2 2021 Aug 06, 2021	BUY	$3.16 - $5.72 $34,728 - $62,862	10,990 Added 3545.16%	11,300 $16,000
Q4 2020 Feb 10, 2021	SELL	$3.43 - $5.23 $33,236 - $50,678	-9,690 Reduced 96.9%	310 $49,000
Q3 2020 Nov 13, 2020	BUY	$4.08 - $9.81 $40,800 - $98,100	10,000 New	10,000 $14,000

8.13M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $465M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.